Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis

Systemic Sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

J Autoimmun

Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network

doi: 10.1016/j.jaut.2025.103391

Systemic Sclerosis

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Rheumatology (Oxford)

Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O, Elhai M, EUSTAR collaborators

doi: 10.1093/rheumatology/keaf016

Gout

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease

JAMA Intern Med

Wang Y, Dalbeth N, Terkeltaub R, Zhang Y, Li X, Zeng C, Lei G, Wei J

doi: 10.1001/jamainternmed.2024.6212

Rheumatoid Arthritis

Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on power of rheumatoid arthritis clinical trials to detect differences in radiographic progression

Rheumatology (Oxford)

den Broeder N, Bolhuis TE, van Herwaarden N, Anne Bergstra S, Bouman CAM, van den Hoogen FHJ, Verhoef LM, den Broeder AA, van der Maas A

doi: 10.1093/rheumatology/keae328

Systemic Sclerosis

Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS)

Rheumatology (Oxford)

Ross RL, Caballero-Ruiz B, Clarke EL, Kakkar V, Wasson CW, Mulipa P, De Lorenzis E, Merchant W, Di Donato S, Rindone A, Herrick AL, Denton CP, Riobo-Del Galdo NA, Del Galdo F

doi: 10.1093/rheumatology/keae698

Gout

An Artificial Intelligence-Based Gout Management System Reduced Chronic Kidney Disease Incident and Improved Target Serum Urate Achievement

Rheumatology (Oxford)

Qi H, Lu J, Dalbeth N, Sun M, Liu Z, Ji X, Ji A, Wang C, Sun W, Li X, He Y, Cui L, Han L, Chen Y, Yan F, Zhang Y, Terkeltaub R, Li C

doi: 10.1093/rheumatology/keae616

Systemic Sclerosis

Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis

Semin Arthritis Rheum

Binda M, Ortolan A, Moccaldi B, Salvato M, Cuberli A, Padoan R, Doria A, Zanatta E

doi: 10.1016/j.semarthrit.2024.152606

Systemic Lupus Erythematosus

Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab

Rheumatology (Oxford)

Parodis I, Lindblom J, Tsoi A, Palazzo L, Sporre KB, Enman Y, Nikolopoulos D, Beretta L

doi: 10.1093/rheumatology/keae575

Systemic Sclerosis

Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis

J Autoimmun

Chevalier K, Chassagnon G, Leonard-Louis S, Cohen P, Dunogue B, Regent A, Thoreau B, Mouthon L, Chaigne B

doi: 10.1016/j.jaut.2024.103220

Related content

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease

Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on power of rheumatoid arthritis clinical trials to detect differences in radiographic progression

Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS)

An Artificial Intelligence-Based Gout Management System Reduced Chronic Kidney Disease Incident and Improved Target Serum Urate Achievement

Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis

Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab

Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis